Drawing for KYBRELLON

USPTO serial 86348038

KYBRELLON

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
WOOD, CAROLINE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with KYBRELLON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

CHRISTOPHER M HANES GLAXOSMITHKLINELEGAL GLOBAL TRADEMARKSMAILSTOP 5 5A FIVE MOORE DRIVERESEARCH TRIANGLE PARK, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 11, 2016MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jan 9, 2016ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 9, 2016OP.TOPPOSITION TERMINATED NO. 999999—
Jan 9, 2016OP.SOPPOSITION SUSTAINED NO. 999999—
Sep 29, 2015OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 30, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 2, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 27, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2015DMCCDATA MODIFICATION COMPLETED—
Apr 9, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2015ALIEASSIGNED TO LIE—
Mar 27, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 12, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 12, 2014GNSLLETTER OF SUSPENSION E-MAILED—
Oct 12, 2014CNSLSUSPENSION LETTER WRITTEN—
Oct 11, 2014DOCKASSIGNED TO EXAMINER—
Aug 4, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance